| MeSH term | MeSH ID | Detail |
|---|---|---|
| Asthma | D001249 | 52 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Femoral Fractures | D005264 | 7 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Hyperemia | D006940 | 25 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Acidosis | D000138 | 13 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Staphylococcal Infections | D013203 | 15 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Eizayaga FX et al. | Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. | 2007 | World J. Gastroenterol. | pmid:17876871 |
| Ciabattoni G et al. | Determinants of platelet activation in Alzheimer's disease. | 2007 | Neurobiol. Aging | pmid:16442186 |
| Ivandic BT et al. | Determination of aspirin responsiveness by use of whole blood platelet aggregometry. | 2007 | Clin. Chem. | pmid:17332149 |
| Calzada C et al. | In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. | 2007 | J. Clin. Endocrinol. Metab. | pmid:17341567 |
| Eligini S et al. | Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. | 2007 | Cardiovasc. Res. | pmid:17250815 |
| Sood BG et al. | PGE2/TXB2 imbalance in neonatal hypoxemic respiratory failure. | 2007 | Acta Paediatr. | pmid:17376184 |
| Bray PF et al. | Heritability of platelet function in families with premature coronary artery disease. | 2007 | J. Thromb. Haemost. | pmid:17663734 |
| Chang MC et al. | Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. | 2007 | Br. J. Pharmacol. | pmid:17641677 |
| Li XM et al. | [Physiological effects of cold and cool Chinese herbal medicine of channel tropism of stomach on rats with stomach-heat syndrome]. | 2007 | Zhongguo Zhong Yao Za Zhi | pmid:17672345 |
| Park JB | Caffedymine from cocoa has COX inhibitory activity suppressing the expression of a platelet activation marker, P-selectin. | 2007 | J. Agric. Food Chem. | pmid:17319684 |
| Holma R et al. | Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. | 2007 | J. Physiol. Pharmacol. | pmid:17928642 |
| Bogani P et al. | Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. | 2007 | Atherosclerosis | pmid:16488419 |
| Sekine S et al. | Lowering systolic blood pressure and increases in vasodilator levels in SHR with oral alpha-linolenic acid administration. | 2007 | J Oleo Sci | pmid:17898500 |
| Jin UH et al. | Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. | 2007 | Phytother Res | pmid:17128437 |
| Shemesh E et al. | Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. | 2006 May-Jun | Psychosomatics | pmid:16684940 |
| Tuominen OM et al. | Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187. | 2006 Jul-Aug | Methods Find Exp Clin Pharmacol | pmid:16894405 |
| Wang LH et al. | Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation. | 2006 Jan-Feb | Clin. Exp. Pharmacol. Physiol. | pmid:16445701 |
| Wynn RL and Cook J | Does ibuprofen block the cardioprotective effects of aspirin in dental patients? | 2006 Jan-Feb | Gen Dent | pmid:16494111 |
| Sciulli MG et al. | Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. | 2006 | Clin. Pharmacol. Ther. | pmid:16890573 |
| Sailaja Devi MM and Das UN | Effect of prostaglandins against alloxan-induced diabetes mellitus. | 2006 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:16297610 |
| Shi T et al. | Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. | 2006 | Arthritis Rheum. | pmid:16868978 |
| Ramamurthy S et al. | Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression. | 2006 | J. Neurosci. Res. | pmid:16998891 |
| Kanda N and Watanabe S | Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. | 2006 | Biochem. Pharmacol. | pmid:16784723 |
| Renda G et al. | Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. | 2006 | Clin. Pharmacol. Ther. | pmid:16952493 |
| Gabler NK et al. | Dietary onion intake as part of a typical high fat diet improves indices of cardiovascular health using the mixed sex pig model. | 2006 | Plant Foods Hum Nutr | pmid:17123162 |
| Venturinelli ML et al. | Platelet activation in different clinical forms of the coronary artery disease (role of P-selectin and others platelet markers in stable and unstable angina). | 2006 | Arq. Bras. Cardiol. | pmid:17128313 |
| Friton GM et al. | Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. | 2006 | Vet. Rec. | pmid:17056651 |
| Ma K et al. | [Study on comparative pharmacology of series of Muskone]. | 2006 | Zhongguo Zhong Yao Za Zhi | pmid:17061560 |
| Myers SI et al. | Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. | 2006 | J. Vasc. Surg. | pmid:16520177 |
| Fu JH et al. | [Protective effects of saponines of stem and leaf of Panax notoginseng on acute myocardial ischemia in anaesthetic dogs]. | 2006 | Zhongguo Zhong Yao Za Zhi | pmid:16548173 |
| Kanazawa S et al. | Aspirin reduces adverse effects of gefitinib. | 2006 | Anticancer Drugs | pmid:16550000 |
| Lee KS et al. | Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. | 2006 | Pharmacol. Res. | pmid:16420980 |
| Yin M et al. | [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro]. | 2006 | Zhongguo Wei Zhong Bing Ji Jiu Yi Xue | pmid:16647015 |
| Ahmad S et al. | Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. | 2006 | Eur. J. Pharmacol. | pmid:16650843 |
| Fontana P et al. | Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. | 2006 | J. Thromb. Haemost. | pmid:16634751 |
| Markuszewski L et al. | Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? | 2006 | Basic Clin. Pharmacol. Toxicol. | pmid:16635110 |
| Cheung PY et al. | Platelet dysfunction in asphyxiated newborn piglets resuscitated with 21% and 100% oxygen. | 2006 | Pediatr. Res. | pmid:16627873 |
| Laleman W et al. | A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. | 2006 | Eur. J. Clin. Invest. | pmid:16620286 |
| Treiber G et al. | The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. | 2006 | Aliment. Pharmacol. Ther. | pmid:16393293 |
| Ahmadzadehfar H et al. | Passive cigarette smoking increases isoprostane formation. | 2006 | Life Sci. | pmid:16165164 |
| Lee KS et al. | Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. | 2006 | Life Sci. | pmid:16153663 |
| Eligini S et al. | Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. | 2006 | Cardiovasc. Res. | pmid:16154551 |
| Nobutoki T et al. | Fluctuating hearing loss, episodic headache, and stroke with platelet hyperaggregability: coexistence of auditory neuropathy and cochlear hearing loss. | 2006 | Brain Dev. | pmid:16168600 |
| Santilli F et al. | Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. | 2006 | J. Am. Coll. Cardiol. | pmid:16412866 |
| Cao D et al. | Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. | 2006 | J. Nutr. Biochem. | pmid:16098734 |
| Yang YY et al. | Roles of anandamide in the hepatic microcirculation in cirrhotic rats. | 2006 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:16407591 |
| Cyrus T et al. | Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. | 2006 | Atherosclerosis | pmid:16326168 |
| Mauri P et al. | LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. | 2006 | J Pharm Biomed Anal | pmid:16343838 |
| Michel F et al. | Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization. | 2006 | Arterioscler. Thromb. Vasc. Biol. | pmid:16385086 |
| Murphy KJ et al. | Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. | 2006 | Asia Pac J Clin Nutr | pmid:16837436 |